rethinkTHC Search
Menu
Study breakdown

Topical capsaicin cream relieved cannabinoid hyperemesis symptoms in all 13 patients treated in the ER

Case ReportPreliminary evidence
The takeaway

All 13 patients with suspected cannabinoid hyperemesis syndrome experienced symptom relief after applying capsaicin cream in the emergency department, even after other treatments had failed.

Read this if you experience cannabinoid hyperemesis or are an ER provider looking for CHS treatment options.

13/13 CHS patients improved with topical capsaicin after other treatments failed

What the researchers found

Thirteen patients with daily cannabis use and symptoms consistent with cannabinoid hyperemesis syndrome (CHS) were treated with topical capsaicin cream at two academic medical center emergency departments. All 13 experienced symptom relief after capsaicin application.

The treatment was used after other approaches had failed. The proposed mechanism involves capsaicin binding to TRPV1 receptors with high specificity, overstimulating them to impair substance P signaling in the area postrema and nucleus tractus solitarius (brain regions that control vomiting). This may explain the antiemetic effect.

Why it matters

CHS is notoriously difficult to treat in the ER. Standard antiemetics often fail, and patients may receive unnecessary testing and prolonged stays. Topical capsaicin cream is inexpensive, widely available, and easy to apply. If these findings are confirmed in controlled trials, it could become a first-line ER treatment for CHS.

The numbers in context

13 patients treated. All 13 experienced symptom relief. Treatment: topical capsaicin cream. Used at 2 academic medical centers. Mechanism: TRPV1 receptor overstimulation impairing substance P signaling.

How the study worked

Retrospective case series. Electronic health records at two academic medical centers were queried to identify patients with documented daily cannabis use, CHS-consistent symptoms, and topical capsaicin treatment. Thirteen cases were identified.

What this study cannot tell us

Retrospective, uncontrolled case series. No placebo comparison. 13 patients is a small number. Symptoms may have resolved spontaneously. The strength and application site of capsaicin cream varied. No standardized outcome measures.

How to read the evidence

Small retrospective case series. Promising results but no control group or standardized protocol.

When this study was published

Published in 2017. Topical capsaicin for CHS has since been studied in additional case series and is increasingly used in emergency departments.

The bigger picture

The capsaicin-CHS connection reveals an intriguing pharmacological interaction. CHS patients often compulsively take hot showers for relief, and capsaicin activates the same heat-sensing TRPV1 receptor. Topical capsaicin essentially provides a concentrated, targeted version of the hot shower effect, offering a more practical treatment in the clinical setting.

Questions still open

  • Would a randomized controlled trial confirm capsaicin's effectiveness for CHS? What is the optimal concentration and application site? How long does the relief last? Could capsaicin be used for outpatient CHS management?

Common questions

How does capsaicin cream help with vomiting?
Capsaicin binds to TRPV1 receptors, the same receptors activated by heat. Overstimulating these receptors is thought to impair substance P signaling in the brain regions that control vomiting (area postrema and nucleus tractus solitarius). This is similar to why CHS patients find relief from hot showers.
Where do you apply the capsaicin cream?
The case series did not specify a standardized application site. In practice, capsaicin cream for CHS is typically applied to the abdomen, but protocols vary. The active ingredient in the cream is the same compound that makes hot peppers hot.

Read the original research

Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.

Clinical toxicology (Philadelphia, Pa.), 55(8), 908-913

Citation

Dezieck, Laurel; Hafez, Zachary; Conicella, Albert; Blohm, Eike; O'Connor, Mark J; Schwarz, Evan S; Mullins, Michael E. (2017). Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.. Clinical toxicology (Philadelphia, Pa.), 55(8), 908-913. https://doi.org/10.1080/15563650.2017.1324166

Explore the wider topic